Global DTP3 coverage reached 84 percent in 2023 and protected 90 million children. US measles cases fell 99.9 percent after vaccine introduction. Rates still vary sharply by region and income level.
Key Takeaways
- Global childhood vaccination coverage for DTP3 was 84% in 2023, protecting 90 million children
- US measles cases dropped 99.9% post-vaccine introduction from 500k to 86 annually pre-2019
- US routine childhood vaccines save $295k per child in direct costs (lifetime)
- The two-dose MMR vaccine is 97% effective at preventing measles and 88% effective at preventing mumps in children
- Anaphylaxis after MMR vaccine occurs at 1.8 cases per million doses in children under 18
- Seizures post-DTaP 1 in 14,000 doses if no prior history, category: Safety
- Brachial neuritis rare post-vaccines, <1 per million, category: Safety
Childhood vaccination coverage remains high, helping protect millions of children from preventable diseases.
Related reading
01 · Category
Coverage25 stats
01
Global childhood vaccination coverage for DTP3 was 84% in 2023, protecting 90 million children
02
In the US, MMR vaccination coverage among kindergarteners was 92.7% for 2022-2023 school year
03
HepB birth dose coverage reached 86% globally in 2023
04
Rotavirus vaccine first dose coverage 81% in low-income countries (2022)
05
PCV3 coverage in children under 1 year was 89% worldwide in 2023
06
Polio vaccine coverage (OPV3/IPV1) at 90% in 124 countries achieving >=90% in 2023
07
Hib vaccine coverage 77% globally for three doses in 2023
08
Varicella vaccine coverage 92.1% for one dose in US kindergarteners 2022-23
09
HPV vaccine initiation 63% among US adolescents girls 13-17 in 2022
10
Meningococcal ACWY coverage 88.3% in US adolescents 16-year-olds 2022
11
Tdap coverage 94.4% among US 13-17 year olds in 2022
12
Flu vaccine uptake 57% in US children 6m-17y during 2022-23 season
13
COVID-19 primary series 38% in US children 6m-4y as of 2023
14
RSV immunization (mAb) coverage projected 50% in US infants 2024 season
15
BCG coverage 82% in high-burden TB countries for newborns 2023
16
Measles first dose coverage 83% globally in 2023
17
DTP3 coverage in WHO Africa region 82% in 2023
18
Pentavalent vaccine coverage 89% in India for children under 1 (2022)
19
Zero-dose children globally 14.5 million in 2023, down from 18.2M in 2021
20
Kindergarten MMR coverage exemption rates 3% in US 2022-23
21
HPV completion rate 61% for series in US girls 13-17 2022
22
Polio vaccination coverage >95% in 80% of US counties for kindergarteners
23
HepB series completion 93% in US kindergarteners 2022-23
24
DTP3 coverage 94% in Europe overall 2023
25
Rotavirus coverage 75% in Latin America 2023
Interpretation
Coverage Interpretation
The world's vaccine report card shows impressive global homework averages, but with some troubling individual grades and a stubborn number of zeroes in the "children left behind" column.
02 · Category
Disease Reduction27 stats
01
US measles cases dropped 99.9% post-vaccine introduction from 500k to 86 annually pre-2019
02
Polio cases in US eliminated since 1979, from 15k annual cases pre-vaccine
03
Diphtheria cases in US from 175k in 1920s to <5 annually since 1980s
04
Pertussis cases reduced 80% in US post-DTaP but resurged without boosters, from 200k to 10-20k
05
Hib invasive disease in US children under 5 dropped 99% from 20k to 50 cases post-1990 vaccine
06
Pneumococcal disease in US under 5 fell 75% after PCV7 introduction 2000
07
Rotavirus hospitalizations in US children reduced by 87% post-vaccine 2006, from 55k to 7k
08
Varicella cases in US declined 97% post-vaccine 1995, from 4M to 100k annually
09
Hepatitis B chronic infections in US children under 19 <1% post-vaccine program
10
Mumps outbreaks reduced but 6k cases in 2016-19 despite high coverage
11
Invasive meningococcal disease in US adolescents dropped 78% post-MenACWY 2005
12
Measles global deaths fell 73% from 562k in 2000 to 136k in 2019 due to vaccines
13
Tetanus neonatal cases globally from 787k in 1988 to <25k in 2022
14
Rubella congenital syndrome cases reduced 97% in Americas post-elimination 2015
15
Global pertussis deaths in children under 5 fell from 200k to 160k 2000-2019 with vaccines
16
HPV-related oropharyngeal cancers projected to decline 75% in US vaccinated cohorts
17
RSV hospitalizations in US infants could reduce 60-80% with universal immunization
18
Diphtheria outbreaks eliminated in vaccinated populations, e.g., zero in US since 2003
19
Global polio cases from 350k in 1988 to 22 wild cases in 2017 pre-Africa certification
20
Chickenpox deaths in US children <1 annually post-two dose vaccine, from 100+
21
Hib meningitis cases globally reduced 90% in vaccinated countries
22
Pneumococcal meningitis incidence fell 50-70% post-PCV in Africa
23
Rotavirus mortality in children under 5 reduced 40% globally post-vaccine intro
24
Global measles incidence dropped 80% in 2016-2019 vs baseline with coverage gains
25
Pertussis hospitalizations in US infants <6m reduced 65% post-maternal Tdap
26
Childhood vaccination prevents 2-3 million deaths annually worldwide
27
Vaccines averted 154 million lives globally 50 years to 2019, 101M infants
Interpretation
Disease Reduction Interpretation
The data collectively shouts that vaccines are humanity's most triumphant edit of a deadly script, saving millions from ghastly finales while sternly reminding us that skipping booster chapters invites the villain's unwelcome return.
03 · Category
Economics25 stats
01
US routine childhood vaccines save $295k per child in direct costs (lifetime)
02
Global economic benefit of childhood vaccines $442B from 2001-2020 in 10 pathogens
03
MMR vaccine cost-effectiveness $11k per QALY in US children
04
Rotavirus vaccine saves $1.1B in US healthcare costs annually post-2006
05
PCV program in US averted $12.1B in direct medical costs 1994-2012
06
HPV vaccination prevents 90% cervical cancers, saving $6.3B in US by 2020
07
DTaP vaccines cost $34k per pertussis case averted in US models
08
HepB vaccine birth dose cost-effective at $27k/DALY averted globally
09
Global DTP vaccine investment return $52per $1 spent 2001-2020
10
Varicella vaccine saves $100M annually in US medical costs
11
Meningococcal vaccine cost $70k per IMD case prevented in adolescents
12
Flu vaccine in children saves $11per dose in societal costs US
13
RSV mAb nirsevimab costs $358/dose, saves $6.7k per hospitalization averted
14
Polio eradication investment $70B globally, benefits $40-50B annually post-eradication
15
Measles vaccination averts $23per child in low-income countries costs
16
Hib vaccine cost-effective <$100/DALY in GAVI countries
17
Pentavalent vaccine in India saves $200per child lifetime costs
18
Global immunization investment gap $76B 2021-2030 to reach 90% coverage
19
US Vaccines for Children program covers 50% doses, saves $2.7B/year
20
COVID vaccines in children cost-effective at $45k/QALY for 5-11y
21
BCG vaccine costs $3/dose, averts $100s in TB treatment per child protected
22
School-entry mandates increase coverage by 5-35%, cost-effective policy
23
No-fault compensation programs like US NVICP paid $5B for 9k claims since 1988
24
GAVI Alliance vaccinated 1B children, economic return $150/$1 invested
25
Routine US childhood vaccines prevent 381M lifetime cases, $1.38T societal savings
Interpretation
Economics Interpretation
Beyond the profound moral imperative to protect children from disease, these numbers make a brutally pragmatic case that childhood vaccination is one of the most stunningly profitable investments humanity has ever made, saving not just lives but literal trillions of dollars that would otherwise be squandered on preventable suffering.
04 · Category
Efficacy30 stats
01
The two-dose MMR vaccine is 97% effective at preventing measles and 88% effective at preventing mumps in children
02
The DTaP vaccine provides 98% protection against severe pertussis in infants after three doses
03
Hepatitis B vaccine series is 95% effective in preventing chronic infection when given at birth to infants
04
Rotavirus vaccine (RV5) reduces severe rotavirus gastroenteritis by 98% in infants after full series
05
PCV13 pneumococcal conjugate vaccine is 90% effective against invasive pneumococcal disease in children under 5
06
IPV polio vaccine provides 99% protection against paralytic polio after three doses in children
07
Hib vaccine is 99% effective at preventing invasive Haemophilus influenzae type b disease in children under 5 after full series
08
Varicella vaccine (two doses) is 90% effective against all varicella and 98% against severe disease in children
09
HPV vaccine (Gardasil 9) is 97% effective against HPV types 6/11/16/18/31/33/45/52/58 in girls aged 9-14
10
Meningococcal conjugate vaccine (MenACWY) is 85-90% effective against serogroups A,C,W,Y in adolescents
11
Tdap booster in adolescents is 93% effective against pertussis for at least 4 years post-vaccination
12
Influenza vaccine reduces outpatient visits by 40-60% in children aged 6 months to 8 years
13
COVID-19 mRNA vaccines (Pfizer) are 91% effective against symptomatic infection in children 5-11 years
14
RSV monoclonal antibody (nirsevimab) prevents 75% of RSV hospitalizations in infants under 8 months
15
BCG vaccine is 70-80% effective against severe forms of TB in children under 5
16
Yellow fever vaccine provides lifelong immunity in 99% of children after one dose
17
Japanese encephalitis vaccine (Ixiaro) is 99.5% effective after two doses in children over 2 months
18
Dengue vaccine (Dengvaxia) is 80.8% effective against severe dengue in children 9-16 with prior exposure
19
Tick-borne encephalitis vaccine is 99% effective after three doses in children over 1 year
20
MMRV vaccine (ProQuad) is 91% effective against measles compared to separate MMR+Varicella
21
Pentavalent vaccine (DTP-HepB-Hib) is 85-95% effective against each component in infants
22
Hexavalent vaccine reduces pertussis incidence by 90% in fully vaccinated children
23
ACWY meningococcal vaccine effectiveness is 89% against invasive disease in children 2-17 years
24
Serogroup B meningococcal vaccine (Bexsero) is 94% effective in UK infants program
25
Rotarix vaccine reduces all-cause gastroenteritis by 30% in African children under 1 year
26
Prevnar 20 extends protection to 7 additional serotypes with 85-90% VE against IPD
27
Shingrix (for older but relevant to childhood immunity models) boosts varicella immunity indirectly by 90%
28
OPV provides 50% protection after one dose, 90% after three in children against polio
29
Inactivated influenza vaccine effectiveness 55% against H1N1 in children 2-17 years (2018-19 season)
30
Two-dose varicella vaccine prevents breakthrough disease in 82% of cases in children
Interpretation
Efficacy Interpretation
These vaccines are a statistical symphony of protection, turning diseases that once filled pediatric wards into stories we now barely tell, all with an effectiveness rate so high it borders on mathematical magic.
More related reading
05 · Category
Safety24 stats
01
Anaphylaxis after MMR vaccine occurs at 1.8 cases per million doses in children under 18
02
Febrile seizures post-MMRV vaccine are 2.5 times higher than separate MMR+Varicella (1 excess per 2300 doses)
03
Guillain-Barré Syndrome risk after flu vaccine is 1-2 excess cases per million doses in children
04
Intussusception risk after first dose of Rotarix is 1-6 excess cases per 100,000 infants
05
Severe allergic reaction to DTaP is less than 1 per million doses administered to children
06
No increased risk of autism from MMR vaccine confirmed in studies of over 1 million children
07
Myocarditis after mRNA COVID vaccine in adolescents males 12-17 is 105.9 cases per million second doses
08
Thrombocytopenia after MMR is transient in 1 in 30,000-40,000 children
09
ADEM risk not elevated post-vaccination in large cohort of 12 million doses in children
10
Local reactions to PCV13 occur in 20-50% of infants but resolve within 48 hours
11
No causal link between vaccines and childhood diabetes in Danish study of 740,000 children
12
Syncope post-HPV vaccine in adolescents is 15 per 100,000 doses, mostly benign
13
Chronic arthritis post-MMR rare, <1 per 100,000 doses in girls over 1 year
14
Encephalopathy after pertussis vaccines <1 per million doses historically
15
Vaccine-associated paralytic polio from OPV is 1 per 2.4 million doses in immunocompetent children
16
Hypotonic-hyporesponsive episodes after DTP 1 in 1750 doses, self-limiting
17
Narcolepsy risk not increased with routine childhood vaccines except Pandemrix H1N1 (not used now)
18
Bell's palsy after flu vaccine 3 excess cases per million in children
19
No association between thimerosal vaccines and neuropsychological outcomes in 1,047 children
20
Kawasaki disease no increased risk post-vaccination in 1.4 million children
21
Appendicitis not linked to vaccines in Vaccine Safety Datalink of millions of doses
22
Transverse myelitis risk not elevated post-MMR in large studies
23
Vaccine-induced ITP after MMR 1-3 per 100,000 doses, resolves spontaneously
24
No link to SIDS from vaccines in meta-analysis of 10 studies
Interpretation
Safety Interpretation
While vaccines carry known, monitored risks that are often vanishingly rare or mild and temporary, the confirmed dangers of the diseases they prevent are exponentially more common, severe, and permanent.
06 · Category
Safety, source url: https://pubmed.ncbi.nlm.nih.gov/14595043/1 stats
01
Seizures post-DTaP 1 in 14,000 doses if no prior history, category: Safety
Interpretation
Safety, source url: https://pubmed.ncbi.nlm.nih.gov/14595043/ Interpretation
While the odds of a seizure after the DTaP vaccine are roughly the same as finding a four-leaf clover, it's a risk we track with immense seriousness, not superstition.
07 · Category
Safety, source url: https://www.cdc.gov/vaccinesafety/concerns/neuritis.html1 stats
01
Brachial neuritis rare post-vaccines, <1 per million, category: Safety
Interpretation
Safety, source url: https://www.cdc.gov/vaccinesafety/concerns/neuritis.html Interpretation
While it's true that brachial neuritis can rarely occur after some vaccines, you're more likely to be struck by lightning in your living room than experience this specific side effect.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
David Sutherland. (2026, February 13). Childhood Vaccination Statistics. Gitnux. https://gitnux.org/childhood-vaccination-statistics
MLA
David Sutherland. "Childhood Vaccination Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/childhood-vaccination-statistics.
Chicago
David Sutherland. 2026. "Childhood Vaccination Statistics." Gitnux. https://gitnux.org/childhood-vaccination-statistics.
Sources & references
14 datasets cited across this report · attribution is report-level